$Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer$
QR Code

QR Code

Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer

Shannon Puhalla, Adam BrufskyUPMC Magee-Womens Cancer Program, University of Pittsburgh, Pittsburgh, Pennsylvania, USAAbstract: Taxane therapy is commonly used in the treatment of metastatic breast cancer. However, most patients will eventually become refractory to these agents. Ixabepilone is a new...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Shannon Puhalla, Adam Brufsky
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2008
Sujets:	Medicine (General) R5-920
Accès en ligne:	https://doaj.org/article/4209a5255f9042edac6dae63e7d778f0
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Bevacizumab in the therapy for refractory metastatic colorectal cancer
par: Mary F Mulcahy
Publié: (2008)

Eribulin mesylate in the treatment of metastatic breast cancer
par: Jain S, et autres
Publié: (2012)

Current neoadjuvant treatment options for HER2 positive breast cancer
par: Abdel-Razeq H, et autres
Publié: (2011)

Therapeutic options in docetaxel-refractory metastatic castration-resistant prostate cancer: a cost-effectiveness analysis.
par: Lixian Zhong, et autres
Publié: (2013)

Metastatic and locally aggressive BCC: Current treatment options
par: Máire‐Caitlín Casey, et autres
Publié: (2021)

Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer
par: Sun S, et autres
Publié: (2014)

Potential role of pemetrexed in metastatic breast cancer patients pre-treated with anthracycline or taxane
par: Li-Yan Zhou, et autres
Publié: (2015)

Drug-eluting scaffold to deliver chemotherapeutic medication for management of pancreatic cancer after surgery
par: Zhan Q, et autres
Publié: (2013)

Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells
par: Xia W, et autres
Publié: (2012)

The use of functional epirubicin liposomes to induce programmed death in refractory breast cancer
par: Liu L, et autres
Publié: (2017)

Emerging role of multikinase inhibitors for refractory thyroid cancer
par: Perez CA, et autres
Publié: (2012)

Ziv-aflibercept in metastatic colorectal cancer
par: Patel A, et autres
Publié: (2013)

The influence of bile salt on the chemotherapeutic response of docetaxel-loaded thermosensitive nanomicelles
par: Kim DW, et autres
Publié: (2014)

Nanomembrane-driven co-elution and integration of active chemotherapeutic and anti-inflammatory agents
par: Erik Pierstorff, et autres
Publié: (2008)

Correlation between radioactivity and chemotherapeutics of the 111In-VNB-liposome in pharmacokinetics and biodistribution in rats
par: Tsai TH, et autres
Publié: (2012)

Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals
par: Farazuddin M, et autres
Publié: (2014)

Nanoengineered drug-releasing Ti wires as an alternative for local delivery of chemotherapeutics in the brain
par: Gulati K, et autres
Publié: (2012)

Antibiotic and chemotherapeutic enhanced three-dimensional printer filaments and constructs for biomedical applications
par: Weisman JA, et autres
Publié: (2015)

In vivo enhancement of anticancer therapy using bare or chemotherapeutic drug-bearing nanodiamond particles
par: Li Y, et autres
Publié: (2014)

An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer.
par: Kelly H Salter, et autres
Publié: (2008)

Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases
par: Kobrynski L
Publié: (2012)

PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma
par: Singh M, et autres
Publié: (2015)

PLGA-Encapsulated Tea Polyphenols Enhance The Chemotherapeutic Efficacy Of Cisplatin Against Human Cancer Cells And Mice Bearing Ehrlich Ascites Carcinoma [Retraction]
par: Singh M, et autres
Publié: (2019)

Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer
par: Zhang L, et autres
Publié: (2020)

Metastatic gastric cancer &ndash; focus on targeted therapies
par: Meza-Junco J, et autres
Publié: (2012)

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
par: Mohamedtaki A Tejani, et autres
Publié: (2010)

New treatment options in the management of IBD &ndash; focus on colony stimulating factors
par: Josu&eacute; Barahona-Garrido, et autres
Publié: (2008)

Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter study
par: Puhalla S, et autres
Publié: (2016)

Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment
par: Zhang L, et autres
Publié: (2017)

A 3D model of ovarian cancer cell lines on peptide nanofiber scaffold to explore the cell&ndash;scaffold interaction and chemotherapeutic resistance of anticancer drugs
par: Zehong Yang, et autres
Publié: (2011)

Preparation of drug-loaded iridium oxidenanocomposites and its application in synergetic sonodynamic/chemotherapeutic therapy against cancer
par: ZOU Weijuan, et autres
Publié: (2021)

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
par: Radhakrishnan Ramchandren, et autres
Publié: (2009)

Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer
par: Zhang B, et autres
Publié: (2017)

Organic functionalization of single-walled carbon nanotubes (SWCNTs) with some chemotherapeutic agents as a potential method for drug delivery
par: Ardeshir Khazaei, et autres
Publié: (2010)

Preference-sensitive decisions of patients with metastatic breast cancer: The need for decision support
par: Julie van de Haterd, et autres
Publié: (2016)

Genomic landscape of extraordinary responses in metastatic breast cancer
par: Sun Min Lim, et autres
Publié: (2021)

New options in the management of intractable ALK(+) metastatic non-small-cell lung cancer
par: Weise AM, et autres
Publié: (2014)

Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib
par: Nooka A, et autres
Publié: (2013)

Photothermal transforming agent and chemotherapeutic co-loaded electrospun nanofibers for tumor treatment
par: Zhao J, et autres
Publié: (2019)

Improved chemotherapeutic efficacy of injectable chrysin encapsulated by copolymer nanoparticles
par: Kim KM, et autres
Publié: (2017)